Product Description: PROTAC BRD4 Degrader-13 (compound 9d) is a von Hippel-Lindau system-based PROTAC BRD4 degrader with a linker that can be coupled to ADC antibodies to form PACs (PROTAC-antibody Conjugates). PROTAC BRD4 Degrader-13 can be coupled to STEAP1 and CLL1 antibodies to degrade BRD4 protein in PC3 prostate cancer cells with DC50 values of 0.025 nM and 6.0 nM, respectively[1].
Applications: Cancer-programmed cell death
Formula: C68H85F2N11O17P2S2
References: [1]Dragovich PS, et, al. Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 2: Improvement of In Vitro Antiproliferation Activity and In Vivo Antitumor Efficacy. J Med Chem. 2021 Mar 11;64(5):2576-2607.
CAS Number: 2417370-71-7
Molecular Weight: 1492.54
Research Area: Cancer
Solubility: 10 mM in DMSO
Target: Epigenetic Reader Domain;PROTAC-Linker Conjugates for PAC